SE409460B - Forfarande for framstellnoing av farmaceutiskt godtagbara syraadditionssalter av aminoglykosidantibiotika - Google Patents

Forfarande for framstellnoing av farmaceutiskt godtagbara syraadditionssalter av aminoglykosidantibiotika

Info

Publication number
SE409460B
SE409460B SE7404636A SE7404636A SE409460B SE 409460 B SE409460 B SE 409460B SE 7404636 A SE7404636 A SE 7404636A SE 7404636 A SE7404636 A SE 7404636A SE 409460 B SE409460 B SE 409460B
Authority
SE
Sweden
Prior art keywords
aminoglycosid
antibiotics
procedure
preparation
acceptable acid
Prior art date
Application number
SE7404636A
Other languages
English (en)
Swedish (sv)
Inventor
D J Cooper
J A Waitz
M Counelis
J Weinstein
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of SE409460B publication Critical patent/SE409460B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • C07H15/236Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE7404636A 1970-06-22 1974-04-05 Forfarande for framstellnoing av farmaceutiskt godtagbara syraadditionssalter av aminoglykosidantibiotika SE409460B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4801770A 1970-06-22 1970-06-22

Publications (1)

Publication Number Publication Date
SE409460B true SE409460B (sv) 1979-08-20

Family

ID=21952308

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7404636A SE409460B (sv) 1970-06-22 1974-04-05 Forfarande for framstellnoing av farmaceutiskt godtagbara syraadditionssalter av aminoglykosidantibiotika

Country Status (20)

Country Link
US (4) US3915955A (xx)
JP (1) JPS551798B1 (xx)
AT (2) AT321458B (xx)
BE (1) BE768796A (xx)
CA (1) CA964650A (xx)
CH (1) CH551965A (xx)
CY (1) CY913A (xx)
DE (1) DE2130113C3 (xx)
DK (2) DK129044B (xx)
FR (1) FR2104762B1 (xx)
GB (1) GB1355260A (xx)
HK (1) HK37977A (xx)
HU (1) HU162896B (xx)
IE (1) IE36434B1 (xx)
IL (1) IL37105A (xx)
KE (1) KE2748A (xx)
MY (1) MY7700325A (xx)
NL (1) NL7108580A (xx)
SE (1) SE409460B (xx)
ZA (1) ZA714013B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787758A (fr) * 1971-11-08 1973-02-19 Scherico Ltd Procede de preparation d'une substance douee d'activite antibiotique contenant un nouvel antibiotique, et de derives de celle-ci
FR2187302B1 (xx) * 1972-06-12 1976-05-14 Scherico Ltd
NL7313668A (xx) * 1972-10-10 1974-04-16
US4063015A (en) * 1973-08-27 1977-12-13 Schering Corporation Garamine and derivatives thereof
DE2511122B2 (de) * 1975-03-14 1977-06-08 Vorprodukt fuer die zubereitung von knochenzement
US4252971A (en) * 1979-07-30 1981-02-24 The Upjohn Company Chromatographic process
US4387219A (en) * 1979-11-13 1983-06-07 Sterling Drug Inc. 2-Hydroxy gentamicin compounds
US4288547A (en) * 1979-11-13 1981-09-08 Haruo Yamamoto Fermentative process for preparing antibiotics of the gentamicin class
US4853372A (en) * 1983-12-22 1989-08-01 Merck & Co., Inc. Non-aqueous ivermectin formulation with improved antiparasitic activity
BE902010A (fr) * 1984-03-28 1985-09-25 Hajdusagi Agraripari Egyesules Nouvelles combinaisons de medicaments ayant un effet synergique et procede pour les preparer.
US5079234A (en) * 1989-03-23 1992-01-07 Bristol-Myers Squibb Co. Inhibitors of aminoglycoside nephrotoxicity
EP0530833B1 (en) * 1991-09-05 1996-04-17 TSUMURA & CO. Process to prepare hard gelatine capsules containing chinese herbal extracts
CN1040177C (zh) * 1993-04-23 1998-10-14 江苏省微生物研究所 一种含1-N-乙基庆大霉素C1a或其盐的药用制剂及制备方法
US5674819A (en) 1995-11-09 1997-10-07 The Lubrizol Corporation Carboxylic compositions, derivatives,lubricants, fuels and concentrates
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
EP2124616A1 (en) * 2007-03-05 2009-12-02 Huvepharma Ad Paromomycin supplemented feedingstuffs for poultry species and use thereof for prophylaxis of histomoniasis, reduction of the horizontal spreading of histomoniasis, and for improved weight gain and feed conversion
CA2888241C (en) 2012-10-16 2020-12-29 Surmodics, Inc. Wound packing device and methods
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
CA2987980A1 (en) 2015-06-05 2016-12-08 Ptc Therapeutics, Inc. Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease
CN105200002B (zh) * 2015-10-27 2019-03-15 福州市鼓楼区荣德生物科技有限公司 产西索米星绛红色小单孢工程菌及其构建和应用
CN112553354A (zh) * 2020-12-24 2021-03-26 福安药业集团烟台只楚药业有限公司 一种快速检测庆大霉素高产菌株的分子生物学方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091572A (en) * 1962-07-16 1963-05-28 Schering Corp Gentamycin and method of production
US3136704A (en) * 1962-12-05 1964-06-09 Schering Corp Manufacture of gentamycin

Also Published As

Publication number Publication date
IE36434B1 (en) 1976-11-10
IE36434L (en) 1971-12-22
AT321458B (de) 1975-04-10
CA964650A (en) 1975-03-18
US4389398A (en) 1983-06-21
DE2130113B2 (de) 1979-10-25
JPS551798B1 (xx) 1980-01-17
IL37105A (en) 1975-12-31
CH551965A (de) 1974-07-31
US4110439A (en) 1978-08-29
CY913A (en) 1977-12-23
NL7108580A (xx) 1971-12-24
DE2130113A1 (de) 1972-01-13
US4049796A (en) 1977-09-20
ZA714013B (en) 1972-03-29
FR2104762B1 (xx) 1975-04-18
HU162896B (xx) 1973-04-28
AT322742B (de) 1975-06-10
US3915955A (en) 1975-10-28
IL37105A0 (en) 1971-08-25
KE2748A (en) 1977-07-22
DK499474A (xx) 1975-06-02
BE768796A (fr) 1971-12-21
DE2130113C3 (de) 1980-07-03
FR2104762A1 (xx) 1972-04-21
DK129044B (da) 1974-08-12
MY7700325A (en) 1977-12-31
GB1355260A (en) 1974-06-05
HK37977A (en) 1977-09-21

Similar Documents

Publication Publication Date Title
SE409460B (sv) Forfarande for framstellnoing av farmaceutiskt godtagbara syraadditionssalter av aminoglykosidantibiotika
NO145883C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-methoxy-7-acylamino-cefalosporansyrederivater
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
SE416812B (sv) Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3-ol-4-karboxylsyraforeningar
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE385118B (sv) Forfarande for framstellning av 2-(6-metoxi-2-naftyl)-propionsyra
SE394678B (sv) Analogiforfarande for framstellning av pyridokinolinderivat
SE380529B (sv) Analogiforfaranden for framstellning av nya azepinderivat
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
NO138883C (no) Fremgangsmaate for fremstilling av oksiranforbindelser
SE397677B (sv) Forfarande for framstellning av en alfa-dipeptidlagalkylester av l-asparaginsyra
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE380522B (sv) Forfarande for framstellning av (1- (p-klorbensoyl)-5-metoxi-2-metyl-3-indol) - acetoxiettiksyra med antiflogistisk verkan
SE403911B (sv) Forfarande for framstellning av aroylsubstituerade fenylettiksyraderivat med anti-inflammatorisk verkan
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE406195B (sv) Forfarande for framstellning av bensocykloheptaisokinolinderivat samt syraadditionssalter derav
SE395897B (sv) Forfarande for framstellning av 7beta-acylamido-3-metyl-cef-3-em-4-karbonsyror
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
SE392611B (sv) Forfarande for framstellning av antrakinonkarboxylsyra
NO140736C (no) Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre
SE407687B (sv) Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat
SE411759B (sv) Forfarande for framstellning av erytromycyliminforeningar